Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Plos One|January 25, 2018
Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matchingVirginia Chamorro, Daniel Morales-Cano, Javier Milara, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 16, 2019
Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M3 Receptor Antagonist/β 2-Adrenoceptor Agonist Molecule with Long-Lasting Effects and Favorable Safety ProfileMònica Aparici, Carla Carcasona, Israel Ramos, et al.
European Heart Journal. Cardiovascular Imaging|August 9, 2014
Prognostic value of pulmonary vascular resistance estimated by cardiac magnetic resonance in patients with chronic heart failureÓscar Fabregat-Andrés, Jordi Estornell-Erill, Francisco Ridocci-Soriano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 25, 2007
CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltrationYafa Naim Abu Nabah, Mercedes Losada, Rossana Estellés, et al.
Antioxidants & Redox Signaling|June 4, 2013
Ceramide mediates acute oxygen sensing in vascular tissuesLaura Moreno, Javier Moral-Sanz, Daniel Morales-Cano, et al.
Clinical Science (London, England : 1979)|July 15, 2016
Activation of PPARβ/δ prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteriesDaniel Morales-Cano, Laura Moreno, Bianca Barreira, et al.
Journal of Leukocyte Biology|January 20, 2018
Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neurtrophil recruitment in vivoRossana Estellés, Lara Milian, Yafa Naim Abu Nabah, et al.
Biochemical Pharmacology|August 26, 2022
Pharmacological characterization of a novel peptide inhibitor of the Keap1-Nrf2 protein-protein interactionMònica Aparici, Mònica Bravo, Elena Calama, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 28, 2009
Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profileAmadeu Gavaldà, Montserrat Miralpeix, Israel Ramos, et al.
Pageof 14